Ulipristal 30 mg tablet clinical trials

Bioequivalence of Ulipristal Acetate 30 mg Tablets: A Single-Dose, Open-Label, Randomized, Two-Sequence, Two Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.

This study looks at two versions of a 30mg ulipristal acetate tablet to see if they work the same way in healthy women. It's a first step to make sure any new medicine is just as good as the original. Only healthy women are needed.